Lancet Oncology

Immunotherapy for prostate cancer in sight

An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer. In just a few years' time, Ipilumumab could be approved as a treatment for ...

May 26, 2014
popularity 5 / 5 (2) | comments 0